Guide Chilean Biotechnology Companies

PROLOGUE
In Chile the research in biotechnology has been fortified by
focusing on the main productive industrial sectors in the
country, such as aquaculture, mining, agriculture and for-
estry. Nevertheless, and thanks to the search of new devel-
opment alternatives, the conducted applied research have
provided with a diversification of the types of companies that
have arisen. Today this sector comprises an ample array of
subsectors such as biomining, biomedicine, biorenewables,
agriculture, aquaculture, environment, food and bioprocess
among others, all of them which are mainly composed by
small and medium companies.
The biotechnology industry in Chile is an emerging sector
that have research, development and innovation capabilities
of high standard, and with highly trained staff as well that can
work transversally among the productive sectors, its versa-
tility making possible to generate new innovations and com-
panies with high growth potential that could lead to patents,
products, processes or services.
Thanks to the effort and compromise of each member, the
leadership and entrepreneurship spirit of those who lead
the biotechnology enterprises association, with the support
of government entities and new R&D policies in Chile, the
sector has been able to carry out the hard task of developing
an own brand that allows to identify Chilean biotechnology,
bioproducts and services with innovative characteristics and
high commercial impact on the market.
We would like to invite you to meet Chilean biotechnology, the
people who’s behind each enterprise, its daily tasks, its dif-
ferentiation grade, its achievements, and grow expectations.
-Patricio Araneda H-
President Asembio

CHILE BIOTECH
ASEMBIO
PRO CHILE
COMPANIES
Activaq
Aeon Biogroup
Aguamarina
AyS lab
Bal Chile
Biocl
Biogram
Biosan
Biosigma
Biotecnor
Cells for Cells
Covarrubias & Silva
Equilab
Genoma Mayor
Neobiotec
Opessa
Silva & Cia
Escuela de Ingeniería Bioquímica - PUCV
Centro Genómica & Bioinformática - U. Mayor
Vaccimed
BIOTECHNOLOGY CLUSTER

08
10
12
16
20
24
28
32
36
40
44
48
52
56
60
64
68
72
76
80
84
88
92

CHILE BIOTECH
Chilebiotech, a sectorial brand for chilean biotechnology,
is an initiative that was born with the objective of promot-
ing the national biotechnology industry in the world, first
in the United States and the Latin America, showing Chile
as a place to invest in research and development.
Chilebiotech is a joint work between the Chilean Gov-
ernment, by its External Relations Secretaryship, with
ProChile, and with the Sectorial Brand Subdirection of the
Asociación Chilena de Empresas de Biotecnología (Asem-
bio), and organization that represents professionals and
companies that participate in research, development, pro-
duction and commercialization of biotechnological prod-
ucts and services.
We look to give continuity to the chilean biotechnological
industry in the United States and Latin America, giving
their associates a light in the international context, pro-
moting the national image around the world with the goal
of promoting competitiveness and entrepreneurship of na-
tional companies, all of this through its brand ChileBiotech.
The aim of this sectorial brand is:
· To position Chilebiotech in the United States and Latin
America markets.
· To facilitate contact generation between represented
companies and those around the world, thanks to the
08 09 Guide Chilean Biotechnology Companies

strategic alliance with BayBio, Asebio and Amcham.
· To promote every biotechnology cluster that has devel-
oped in Chile.
In Chile, the biotechnology sector is an emerging and
global one, having the capabilities of promoting in a hori-
zontal way most of the national industries, as well as the
creation of new companies with high growth potential.
The focus of the brand is to generate encounters and ne-
gotiations among companies and with those of the Unit-
ed States (mostly because their industrial leadership in
entrepreneurship, investment and development), but also
looking for networking with Latin America’s companies
thanks to the Pacific Alliance of which Chile is a member.
Because of this Chilebiotech participates in different ac-
tivities, events and fairs that allow it to position the brand
in the market, establishing strategic alliances and net-
works with national and international companies, work-
ing alongside BayBio, Asebio and Amcham.

ASEMBIO
Asociación Chilena de Empresas de Biotecnología (ASEM-
BIO), was born on 2004 to improve the development and
cooperation between companies and all other national
organizations of the biotechnology sector. Today it counts
more than 50 companies who work in different areas of
this science. In spite of its relative short time, the Associ-
ation has been capable to establish strong relationships
with government entities and international organizations
that promote biotechnology both in Chile and the rest of
the world.
Asembio is a member of the Federación Latinoamericana
de Empresas de Biotecnología – FELAEB – and has tight
relationships with other similar organizations like Bio-
technology Industry Organization – BIO - , making pos-
sible to their associates to access a wide network of the
biotechnological industry.
Asembio is currently working to improve its representa-
tion by including more companies and other stakeholders
that weren’t considered the first time, like universities with
research capabilities, technological centers and transna-
tional companies that have biotechnological process in
their production line. The objective is to position Chilean
biotechnology in the United States and Latin America, giv-
ing their associates a light in the international context and
fortifying national competitiveness and entrepreneurship,
particularly by the use of the ChileBiotech brand.

On a national level, Asembio looks to generate interest on
other companies, being an inspiration for the
establishment of new business lines, opening the market
for new technologies. This would position Chile as a bio-
technological center on an international level.
In all its tasks, every year Asembio shows chilean biotech-
nology in international fairs, like BIO International
Convention in the United States, Biolatam and Biotechni-
ca in Europe.
In Chile, the biotechnology area has an ample array of
sectors, among them:
· Biomining.
· Biomedicine.
· Biorenewvable.
· Agriculture.
· Aquaculture.
· Environmental biotechnology.
· Food biotechnology.
· Bioprocesses.
Most of the investigation in biotechnology done in Chile
is geared towards the needs of exportation industries,
like aquaculture, mining, agricultural and forestry sector.
Nevertheless, Asembio looks to diversify the number of
companies and sectors that develop new technologies and
are apt to international commercialization.
Mission
We want to be the voice of professionals and companies
that are involved in the search, research, development,
production and marketing of biotechnology.
By way of entrepreneurship and innovation, we want to
promote and further our work, generating a sustainable
commercial development of the chilean biotechnological
industry.
Sectorial
· National and international dialogue and promotion.
· To facilitate the relationship between the private and ac-
ademic sectors.
· To facilitate alliances for research and development on a
national and international level.
· To create conscience in society of the importance of bi-
otechnology.
· To have and active participation within the regulatory
standards of the industry.
Entrepreneurship
· To develop regional/national/international networks.
· To fortify biotechnological innovation and entrepreneur-
ship as an essential factor for the economic growth of the
country.
· To develop technological transfer capabilities and hu-
man resources.
International
· To promote industry internationalization.

PRO-CHILE
ProChile is the entity in charge of promoting chilean goods
and services exports, attracting external investment.
They lend their experience, information and knowledge to
all the country, aiming to facilitate the internationalization
process for all those companies that wish to export or that
could export in the near future. It looks to intensify the
production of goods and services, and associative work
between companies, integrating both public and private
sectors with the common goal of promoting the economic
development of the country.
With different tools and services adjusted accordingly to
the needs of exporters in the process of internationaliza-
tion, ProChile looks to add value to products and services
that composes the offer given, generating more and bet-
ter business opportunities for Chile.
It has a national network composed by 15 Export Centers,
on in every region of the country that helps every com-
pany that wishes to export worldwide. Every one of this
centers have a team of professionals that know regional
production characteristics and are capable of orienting
exporters with specialized information that will facilitate
the opening process.

In the same way there is an external network composed
by 54 Commercial Offices, strategically located in the
most important markets around the world, and open for
everyone that need their services. All of them have profes-
sionals that are constantly monitoring opportunities, ten-
dencies and requirements of those markets, connecting
what is offered in Chile with importers, distributors, and
leaders whose opinion are important in their countries.
Besides promoting the economic development of Chile,
our work includes transmitting the image of our coun-
try throughout the world, so our products and services be
recognized not only by their quality but also for their origin
and other attributes that Chile has, like our people, ge-
ography, array of climates, political, social and economic
stability, among others.

Services Offered
Last generation of biotherapeutics in veterinary industry of
aquaculture. We aim to the animal production market with
safe, sustainable and high efficiency biological products.
We developed a fish behavior control at immune response
level (Inmunetrack ®) and oxidative stress control (Oxitrack
®) technology.
Private and public Project collaboration
Activaq participates in “Ictio Biotechnologies”, Aquaculture San-
ity Technological Consortium for transmissible disease preven-
tive tools development. This consortium, funded in January 2014
is composed by five research entities: Blumar, Ventisqueros,
Australis, USACH and Activaq, and is founded with $7 million
USD (50% of total founding) by a contribution from the Chilean
Goverment (CORFO) for the next seven years.
”We develop products of biological origin for therapeutical ends in aquaculture, with
a preventive look as we develop sanitary solutions, optimizing the production without
greater harm to the environment”
-Geraldine Mlynarz-
Name Activaq S.A.
Adress General Del Canto 460, Providencia
Postal Code/City 7500652, Santiago
Legal Representative Geraldine Mlynarz
Contact Geraldine Mlynarz
Phone +56 2-22363022
E-mail geraldine.mlynarz@activaq.cl
Web Site www.activaq.cl
Number of Colaborators 13
Founding Date 2011

“Integral preventive treatments
through biotherapeutical
processes in aquaculture”.

WHO WE ARE
Activaq is a biotechnological company oriented to solution
development in the sanitary area of veterinary, producing
animal food with emphasis in aquaculture. The company is
dedicated to the development of biotherapeutical processes
for salmon industry. It also has an area of immunogenomics
with its laboratory for dioxin detection, on which its technol-
ogy is founded.
Years of experience in research and development have al-
lowed Activaq to implement platforms that lead to the animal
production market with biological products that are effec-
tives, safe and sustainable.
WHAT WE DO
The company have many years of experience allowing them
to understand the relationship between research and indus-
try, generating instances for connections between universi-
ties, organizations and the industry, promoting technological
transfer as a coordinating partner between them.
Currently is organizing a technological consortium, “Ictius
Biotechnology”, between five partners, implementing a new
cooperation model between public and private stakeholders.
Its aim is to work on fish immunity through biotherapeutic
technology, minimizing the risk to the final consumer and the
environment.
Activaq differentiates themselves from the competition by
offering an integral array of products and services. By be-
ing capable of monitoring the level of immune response and
the oxidative stress on fish, Activaq can condition the gene
expression with biotherapeutics, favoring control and protec-
tion of diseases in salmonids.
THE FUTURE
The next challenge is to consolidate and finish the eleven
projects currently in execution, each of them a different ap-
proximation to know diseases of national and international
importance in aquaculture, having these products available
in no more than five years from now.

” We develop a natural biotechnology that imitates the high efficiency of nature and is
capable of unlueash the full potential of life. One of our products is Algae Circle, based on
a cellular functioning, we design cultivation plants as a living organism.”
-Alfonso Navarro Echenique-
Services Offered
Commercial culture facility of Spirulina in Chile as a “key-in-
hand” project.
Algae Circles advanced cultures technology.
R&D project development in microalgae.
AEON - Algae Circles Prototyping
CORFO, 11IEI-12851 Algae Circles scaling.
FIA PYT2011-0051 Spirulin production with CO2 from wine
fermentation.
CORFO - Fundacion Chile -DHA-rich autotrophic microalgae.
CONICYT - UCV - Phytases production via genetically modi-
fied microalgae.
FIA - Austral Biotech - Salmonid immunostimulant microal-
gae development
Name Aeon Biogroup SpA
Adress El bosque sur 77 of 1, Las Condes
Legal Representative Alfonso Navarro Echenique
Contact Alfonso Navarro Echenique
Phone +56 9-92258585
E-mail anavarro@aeonbiogroup.com
Web Site www.aeonbiogroup.com
Founding Date 2010

“Biotechnology
that simulates nature”.

WHO WE ARE
Aeon Biogroup is a company that develop innovative systems
for microalgae cultivation, focusing on biomass production
for food, oils, nutraceuticals and biochemical products.
The main point of Aeon is in its microalgae cultivation tech-
nology, with their exclusive design Algae Circle, which is a
technology that uses HPBR (hybrid photobiorreactor) and can
facilitate the cultivation of microalgae, incorporating carbon
dioxide that is compatible with an industrial scale production,
without losing yield and efficiency.
WHAT WE DO
Aeon Biogroup has developed a cultivation methodology that
encompasses a tank and all the necessary equipment need-
ed for algae photosynthesis with solar radiation. This method
allows to cultivate different strains, but it has been optimized
for commercial production, like those that generate fatty ac-
ids rich in omega 3 or DHA.
The main advantage of our system is a better yield by area
than the conventional systems, and with a product of better
quality. Although the installation cost is a little bit higher, the
operation costs associated with the system are lower than
other alternatives.
We bring effective and innovative technologies to the industry,
not only as a way to produce on an industrial scale, but also
from the commercial point of view. For this it has a sister com-
pany named “Aqua Solar”, who dedicates to the commercial
aspect of the business, offering the microalgae cultivation
system as a fully operational packet to investors who want to
enter the industry, taking care from the site preparation, staff
contracts, system installation, and distribution management.
With this it applies the concept of “key-in-hand”, making it
easier for the investor to control its operation.
Currently Aeon is selling plants to produce spirulin, but it will
soon have a design to cultivate Chlorella, and in no more than
a year, a system for species that produce DHA.
THE FUTURE
Investment in biotechnology has always been a high risk en-
deavor. However Aeon Biogroup has taken care of all the previ-
ous steps needed to not just only make a technological transfer,
but to minimize all potential risks present, giving a fully tested
alternative. This makes our offer a more secure investment for
potential investors. Our challenge is now to grow the number of
designs so as to reach a bigger market in the microalgae indus-
try.
We are constantly testing our technology in an industrial scale,
allowing us to offer this system as an alternative on a world-wide
range, bringing new clients and investors to this area of biotech-
nology, minimizing their risks. Aeon Biogroup can and will facil-
itate this entry, taking advantage of the potential that the natural
conditions have in Chile.

”In agua Marina we seek for solutions to problems arising
in the mining industry, and we would like to be recognized
as an innovative company, a company that it’s capable of
taking the knowledge derived from test tubes and take
them to industrial applications in a fast way.”

-Pamela Chavez Crooker-
Name Aguamarina S.A.
Adress General Borgoño 934 of. 403
Postal Code/City 1270242, Antofagasta
Legal Representative Pamela Chavez Crooker
Contact Pamela Chavez Crooker
Phone +56 9-98957049
E-mail pchavez@aguamarina.cl
Web Site www.aguamarina.cl
Founding Date 2007
Services Offered
Developers biotechnology for the mining industry.

“Technological developers”.

WHO WE ARE
Agua Marina is a company dedicated to biotechnological de-
velopment, with a focus in the mining industry, to resolve the
great challenges of this industry, like particle material con-
trol, use of hydric resources, biocorrosion, bioleaching, and
other areas.
Agua Marina is part of a new type of companies in the country
which have been developing on the last few years, and that
make a lot of innovation through research and development.
We center in an applied research, complementing industrial
biotechnology.
WHAT WE DO
Today the specialization level of Agua Marina is one of the
highest, and it’s involved in frontier problems of biotechnolo-
gy and industry. Even with their capabilities to make products
and offer services, companies often lack the vision needed
for the application of their products, or needs more infor-
mation about industrial escalation for their process, a point
where Agua Marina enters and take part. Besides being a
developer and have its own products and services, it also has
distribution channels for the needs of the mining industry, for
biotechnological products and services. On the other hand
it combines scientific research with process and industrial
developments.
Agua Marina is a relevant actor that develops technology,
specifically alternative technology as solutions for process
problems and that as today lacks other solutions available or
have a high cost associated. It is because of that that biotech-
nology offers more economical alternatives, and even if cost
the same, is it more environment friendly. We look to improve
value and sustainability to industrial process.
Currently the company has clients in the United States, the
Japanese Government, exploration projects in Chile and Peru
with Anglo American. We believe in an expansion to Peru, Co-
lombia and Mexico as well.
THE FUTURE
In the near future the company would want to become a tech-
nological center in the region, relating investment funds with
biotechnological products escalation; forming new networks
between the community, industry and research, generating
a positive and effective contribution to the community. To in-
corporate technological development in the mining industry,
and make them available to other industries as well, like ag-
riculture, aquaculture and others.

”Our main resource is our wide experience supported by a high amount of projects exe-
cuted, also, the recognition and service outsourcing by the Chilean Agricultural and Live-
stock Service (SAG) provides us in an reliable organization in agriculture and livestock
market”
-Mónica Santalices A.-
Services Offered
· Diagnosis and analysis in the agricultural, livestock and food
sector.
· Advising services in: biotechnological projects, implementation
of analytical methods, quality standards and patenting.
· Technical support with analytical instruments.
· Training in analytical and technical methodologies.
Commercialization of:
· Certified and traceable standards and patterns.
· Process and analytical instrumentation related projects.
· Public projects: Corfo, FIA, Fondecyt, Conicty.
· Private projects for companies in the plaguicide area: bio-
products, vineyards, olive crops, mining industry.
Name AyS Lab
Adress Portugal 1501
Legal Representative Mónica Santalices A.
Nibaldo Apablaza R.
Contact Mónica Santalices A.
Phone +56 2-25551260
+56 9-92318903
E-mail ayslab@ayslab.cl
Web Site www.ayslab.cl
Founding Date 1993

“Advice and R&D&i services with
extensive experience”.

WHO WE ARE
AySLAB is an advice and diagnosis laboratory in agricultural,
livestock and food areas, founded in 1993, it offers nematods,
bacteria, virus and fungi analysis with standard procedures
and from 2005, international food market analysis protocols
and standards were incorporated in AySLAB.
WHAT WE DO
AySLAB started their operations in 1993 with an important
client portfolio which belongs to the highest agriculture and
livestock activity in Chile, these clients supports AySLAB
experience, they constantly requests R&D studies in the re-
search and deploy steps.
AySLAB has a multidisciplinary professional team and the
highest infrastructure laboratory for project, analysis, ad-
vice and biotechnological service development, which can be
classified in Plant Biotechnology, Food Biotechnology, Molec-
ular Analysis, Microbiology, Bioprocesses and Biotechnology
Projects.
All these services that AySLAB offers are based on innova-
tive solutions, environmentally friendly and at what the cli-
ent needs. They also offer project writing services, financing
source search, new business and/or productive unit devel-
opment.
THE FUTURE
To evolve as an analysis service, mainly increasing our field-
work team, as our strongest factor that grows as a future
differentiation unit because it allows increasing customer re-
lationships and have new clients.
The main challenge is to develop us in food area, focused
in international markets streams which is harder than local
markets, so we can get into Latin America agricultural and
livestock markets.

“We are an innovative company, seeking new markets not yet explored that have high
potential. We want to be recognized as pioneers and leaders in commercial cultivation of
brown algae in Chile, and in applied research for value generation”.
-Javier Infante-
Services Offered
· Macroalgae cultivation: Seedlings and biomass production of
Macrocystis pyrifera.
· Algae biomass transformation into biofuels and chemicals of
high market vaue.
·Analysis laboratory.
· Project 09CTEI-6866 “Biotechnological consortium for
R&D&i for biofuels production from the algae Macrocystis
pyrifera” Innova Corfo.
· Project 12IEAT-16310 “Research, development and pro-
curement of chemicals of high market value in global mar-
kets, from native chilean macroalgae” Innova Corfo.
Name Bal Chile S.A.
Consorcio BalBiofuels S.A.
Adress Camino a Chinquihue km.6
Postal Code/City 5480000, Puerto Montt
Legal Representative Javier Infante R.
Daniel Chamorro
Contact Javier Infante R.
Phone +56 65-2335579
E-mail info@balchile.cl
Web Site www.balbiofuels.cl
Founding Date 2011

“Leaders in applied research and cultivation
for the commercialization of macroalgae”.

yield and making it feasible on an economic consideration.
These two technological platforms will generate important
productive capabilities in the country, as well as further re-
search and development associated with them, obtaining in-
novative technologies with which produce the raw material
and its posterior processing, contributing to the diversifica-
tion of aquaculture in the country, and the research in bio-
fuels production and renewable chemicals.
BAL is the only company in Chile and the world that has a
cultivation system for Macrocystis pyrifera that functions on
a commercial scale. After four years of investigation and sca-
ling up, we can obtain algae on a consistent and sustainable
basis. Algae are excellent as a raw material but the natural
prairies doesn’t’ support commercial exploitation, reason
why the future of the algae industry must rely on sustainable
production systems. Our experience and technology for their
cultivation can deliver to the needs of the industry, and we
have more than 3.500 [Ha] of aquaculture concessions at the
south of Chile, basis for the algae industry developing.
THE FUTURE
We want to be leaders in algae culture as part of this rising
algae industry with high potential in Chile, producing raw
materials and products with a high economic potential to su-
pply local and international markets. We will incorporate new
species who will allow us to amplify new products spectra,
growing even higher with our laboratory and pilot plant to
raise our capacity of processing, research and development.
WHO WE ARE
Bio Architecture Lab (BAL) is a company dedicated to biote-
chnology and cultivation systems, that has managed to in-
tegrate two key technological aspects for the development
of a competitive and sustainable production process for a
number of products, all based on macroalgae (Macrocystis
pyrifera) as raw material, particularly for biofuels, chemicals
and food ingredients.
WHAT WE DO
The main developments of the company consists in two ser-
vices:
1. Cultivation technologies: BAL has developed a new tech-
nology for massive production of the algae Macrocystis pyri-
fera in a suspended state, obtaining productivities up to 250
[ton/Ha*year]. Simultaneously BAL is developing a program
for genetic improvement for the algae, looking to improve the
yield and to develop new varieties of commercial interest for
different markets.
2. Pre-treatment and fermentation technologies: This tech-
nology was developed and patented by Bio Arquitecture Lab
Inc. in the United States. Different microorganisms were de-
veloped by biological synthesis and computational enzymatic
design, which are capable of fermenting constitutive sugars
of brown algae, producing ethanol and other chemical com-
pounds of commercial interest. We are currently in an opti-
mization stage of the process, looking to improve the overall

Name Biocl S.A
Adress El Litre 1685, Esquina Plath, Santa Inés
Postal Code/City 2530334, Viña del Mar
Legal Representative Patricio Araneda Herrera
Contact Juliana Castro Londoño
Phone +56 32-2111306
+56 9-68197973
E-mail jcastrol@biocl.cl
Web Site www.biocl.cl
Number of Colaborators 0-50
Founding Date 2012
Services Offered
· Biotechnological hardware pilot and laboratory scale.
· Bioproduction services.
”We are a strategic ally for investigation, development,
innovation and optimization of our client’s process. We
are involved from the conceptualization process to the im-
plementation and operation of our designed equipment,
which includes both training and advice to your team of
professionals.”

-Juliana Castro Londoño-

“Design, production and capacitation
in biotechnological hardware”.

WHO WE ARE
We are a company that develops biotechnological hardware
to meet the specific needs of our clients. Within our produc-
tion capabilities we have bioreactors, autoclaves and differ-
ent designs that can be modified by special request of our
clients, delivering a new alternative to the biotechnological
industry with more versatile and efficient equipment.
As we want our process to meet clean production standards,
minimizing our impact on the environment, we have adopted
ISO 9001:2000 regulations within all our processes.
WHAT WE DO
Our main competitive advantages arises from our profes-
sional team, whose ample experience with reactor design,
biological processes, and equipment instrumentation, con-
trol and operation, allows them to incorporate your own par-
ticular needs in the design of the reactor itself, giving you an
equipment that suits to your own particular line of work.
We accompany you from the conception and design of the
equipment, to its first operation, training the staff responsi-
ble for its functioning and following up your progress in time,
always available if any needs or questions should arise.
Because of our versatility of work, our clients come from dif-
ferent types of backgrounds, from universities and investiga-
tion centers, to different kind of business with biotechnologi-
cal processes, both on a national and international level.
THE FUTURE
The growing industry of biotechnology requires high quality
instrumentation and equipment, within a frame cost that al-
lows them to be used by research and development activities.
With this in mind, BioCL has taken as its mission to become a
partner with their clients, developing new ways to adjust the
equipment to their needs.

”Our main purpose is to capture the best of technical, scientific and economic elements
to build efficient biotechnological products geared towards the need of the agricultural
industry.”
-Pedro Miranda M.-
Services Offered
· Biological products for agricultural production industry, owners
of extensive distribution networks.
· Participates as FONDEF Project associated enterprise with
multiple universities.
· Participates as INNOVA Project associated enterprise in-
collaboration with many research institutes and universities.
· Runs INNOVA direct financing projects.
Name Biogram S.A.
Adress Los Canteros 8534, La Reina
Legal Representative Jaime Quiroz García
Contact Pedro Miranda M.
Phone +56 2-24345144 (Anexo109)
E-mail pmiranda@biogram.cl
Web Site www.biogram.cl
Founding Date 2004

“Especific biotechnological wares for the
new challenges in the agroindustry.”.

WHO WE ARE
Biogram is a company that produces and commercializes bi-
otechnological wares for the agroindustry. Most of our prod-
ucts are living organisms that have a relationship with agri-
cultural activities, plant, trees and crops strengtheninig, or
to control pests and diseases. Our professionals are special-
ized in microbiology, biotechnology and process engineering,
making them capable to confront both commercial products
and process and development.
WHAT WE DO
What differentiates them is our professional team that have
great experience in biotechnology, and is actively involved
with the environment. Is this team, as a result of their contin-
uous and innovative work with the problems that the industry
has today, that have been capable to develope new solutions
like biocontrollers, fermentation process’s innovations and
organic products for the development of new biotechnologi-
cal solutions.
Our knowledge in this kind of specific solutions have sig- nif-
icantly contributed to the challenges assumed by Biogram
to give new solutions to the agroindustry. We have a strain
collection of fungus, yeast and bacteria that are certified on a
global scale, having the specific goal to provide for the needs
of their clients.
Innovation is one of the fundamental pillars of the company,
moving us to the development of new products for the dis-
tribution chain, helping our own distributors, with the cold
chain concept. Applying this concept, products can be well
maintained in periods of high demand, minimizing losses
and spoilage during their shelf life. Thus, Biogram becames
a ally for their partners.
THE FUTURE
Currently the company is developing a project that could pro-
duce an important improvement in biological products dis-
tribution. The limiting factor for massive biological products
distribution is their insufficient shelf life. If we have good re-
sults in this project, we’ll be able to better support our distrib-
utors and clients, both organic and conventional, by means
of the possibility of deliver more competitive products to be
commercialized in the country and overseas. If this accom-
plishment takes place, Biogram will probably be the leading
company in biotechnological development of the country and
the region, making a positive contribution to society as well.

Services Offered
· Human Health
· Animal Health
· Plant Health
· Distribution
· Projects
· Molecular diagnostic kits to detect the 40 principal human
pathogens through real time PCR.
· Development, validation and implementation of a quick
technique for the identification of quarantine Pseudococ-
cides through molecular tools (PCR), to minimize quarantine
rejection of the chilean fruit exports.
· Development, validation and implementation of a quick
technology for detection and differentiation of national and
generic strains for Clostridium difficile bye multiple real time
PCR.
· Technical feasibility for the development of molecular tools
for diagnosis and control of the canine distemper virus.
Name Bioscan S.A.
Adress Dr. Carlos Charlín 1486, Providencia
Legal Representative Ricardo Perales Aravena
Contact Ricardo Perales Aravena
Phone +56 2-23740884
E-mail bioscan@bioscan.cl
Web Site www.bioscan.cl
Founding Date 1993
“Our main challenge is to the market to value the method of molecular analysis above
the conventional prevention analysis, because their efficiency is near 100%, even saving
lives in the process.”
-Ricardo Perales Aravena-

“Molecular biology pioneer”.

WHO WE ARE
Bioscan is a company with 21 years of experience, being the
oldest company in Chile and Latin America dedicated to molec-
ular biotechnology. From its foundation it has been dedicated
to the research in numerous diseases, using the tools given by
molecular biology, realizing that this branch of science offered
methodologies that could be used to develop new screening and
diagnostic technologies that could have more specificity than
conventional technologies, and could be used on humans as
well as on animals and vegetables.
The company has developed 52 different types of tests using PCR
techniques, and another 11 using more conventional means.
They are grouped in four different diseases families: gynecolog-
ical, respiratory systems, systemic and periodontal. There also
exists numerous tests for animal and plant health.
What differentiates them is the human resources, professionals
of different areas from engineering to most of the basic scienc-
es. This allow Bioscan to work on projects from different areas
and industries, having most of the equipment needed for this
endeavor.
WHAT WE DO
Today Bioscan is the biotechnological organization that offers
the biggest array of pathogen detection tests using molecular
biotechnology, as this kind of tests can detect any organic ma-
terial on the samples. We also do genotyping of animal, vegetal
and bacterial sources.
The company have a Research and Development Department
whose function is to develop projects directed to applied mo-
lecular biotechnology research, aiming to generate commercial
products through private and public funding. Currently they are
developing a prototype directed to give solution to intrahospital
diseases like Clostridium difficile, as the current techniques
used today are not very effective for its detection. The technology
developed by Bioscan could make an early detection of the pres-
ence of the disease, allowing to minimize the rate of contagion
and death because of it.
Another development in the animal world is a strategy to diag-
nose in a more effective way the canine distemper. We are aware
of the constant mutation of this particular virus, and are not the
same around the world, so local investigation gains new impor-
tance.
Bioscan have a department to represent 16 international brands
on equipment and materials for molecular biology, giving them
the capabilities to distribute to institutional laboratories both
equipment and reagents.
THE FUTURE
We look forward to create a new unit for preventive medicine,
giving us the opportunity to offer a full service being the diagnos-
tic area just one of many areas and products, as the challenge
today is to offer new methods to solve different clinical problems.
In this way we look to become more than just an alternative, we
would like to path a way to a more efficient diagnosis system and
viable methodologies for patient recovery, helping to improve the
quality of life of patients, the animal and vegetal world, through
Bioscan’s developed technologies.

“Biosigma offers today to the mining industry the capa-
bilities to extract ores with more efficiency, improving
copper yield from the same resource, using biological
techniques and integrating biotechnological methodolo-
gies in the industry”.
-Pilar Parada Valdecantos-
Name BioSigma S.A.
Adress Panamericana Norte km.16,5 - Lote 106,
Industrial Park Los Libertadores, Colina
Legal Representative Pilar Parada Valdecantos
Contact Miguel Bustos Moreno
Phone +56 22-4379030
E-mail mbust021@biosigma.cl
Web Site www.biosigma.cl
Founding Date 2002
Services Offered
· Biotechnology for mining
· CORFO - Capacities strengthening.

“Designing biotechnological solutions
for the mining industry”.

Our vision is to be the preferred biotechnological company to
give our clients a biotechnological solution in a sustainable
way, adding value to their processes. BioSigma is an inno-
vation based company, which is mainly driven by our people
creativity and teamwork that ends in a better service for our
clients to produce meaningful solutions for current problems
in the mining industries.
THE FUTURE
After more than 10 years of existence, today the company has
validated their technologies for bioleaching copper sulfide
ores at industrial scale and now is looking for the applica-
tion of their technologies at a commercial level. BioSigma
has a Research, Development and Innovation area that has
world class competences in microbiology, molecular biology
and metallurgy among other disciplines, together with an on
site operation experience that allows the company to face any
new challenge of the mining industry.
WHO WE ARE
Biosigma is a biotechnological company for the mining in-
dustry, founded in the year 2002 as a joint venture between
Codelco (a government mining company) and JX-NMMC, a
Japanese company that accepted the challenge of integrat-
ing new technologies in the area, including genomic devel-
opment, proteomics, leading the mining industry to the bio-
technology world.
In their first five years their dedication was exclusively ded-
icated to intellectual property development through patent-
ing and patent application, meaning that today we have more
than 120 patent application, 77 of them already granted in
Chile, 11 of them on an international basis, representing one
of the main assets of the company.
WHAT WE DO
BioSigma’s value proposition today is offering to mining compa-
nies the possibility of getting more copper in an efficient way, by
the application of integrated biotechnological solutions. As each
mining site is different, our company designs taylored made
solutions for each case. We give a unique solution for every
unique problem that arises in the industry, which is only possible
with a high qualified team as the one in Biosigma.

“Biotecnor works in biotechnology furthering its reach, developing a synergy between
the academic and industrial worlds”.
-Cecilia Demergasso-
Services Offered
- Characterization and evaluation of bacterial populations.
- Bioleaching tests.
- Development of biotechnological process.
- Hydrometalurgical services.
- Other services.
- Innova 13IDL1-25455 “Technological package for industrial
wastewater treatment with electrodialysis using microorga-
nisms as an energy source”.
- Fondef D04i1169 “Development of a control and monitoring
system of genetic expression for optimization of bioleaching
process of sulphured copper ores”.
- Conicyt IPI 23 “Development on a preliminary laboratory
scale, biotechnological processes and tools to be transferred
to the chilean and international mining industry, selected
from an array of needs detected”.
- Conicyt IPC 51 “Incorporation to Biotecnot Ltda. Of com-
petneces in the proteomic area to be used in developments
related to geomicrobiology and biomining”.
Name Biotecnor Ltda.
Adress Avelino Contardo 1304
Mail Box Casilla 54, Correo Universidad
Católica del Norte, Antofagasta.
Postal Code/City 1270709, Antofagasta.
Legal Representative Williams Saavedra Alcayaga
Contact Williams Saavedra Alcayaga
Phone +56 55-2355486
E-mail biotecnor@biotecnor.cl
Web Site www.biotecnor.cl
Founding Date 2002

“Mining biotechnology. Academic and en-
trepreneurial world synergy”.

WHO WE ARE
Biotecnor Ltda was born from a project t of the Universidad
Católica del Norte, dedicated to biotechnology associated to
mining process and geomicrobiology of arid zones, which
are its specialties. It dedicates both to production process as
the generation of biotechnological tools that are needed for
those very same processes. In the same way, we develop new
products and process from the existent microbial diversity
in the north of Chile, without leaving aside the generation of
new knowledge.
WHAT WE DO
Biotecnor Ltda has an important place in the mining clus-
ter of the region, recognized for its biotechnological services
and the capacity of looking for new developments, improving
control and monitoring tools of industrial process, following
current standards in microbiology.
From another point of view, we are developing new studies
and identifying the microbiology existent in the arid zones of
the north of Chile, mainly at the Desierto de Atacama, whose
microbiological diversity can lead to new discoveries and
products for the pharmacological industry, specifically anti-
biotics and cosmetological products.
Biotecnor Ltda has also worked in partnership with NASA
of the United States, in projects related with the developing
of a new robot for astrobiology. It also has worked with the
University of Arizona, and the European Space Agency (ESA)
as well.
However, the main research lines of Biotecnor are in biomin-
ing, geomicrobiology and the developing of new products as a
result of the study of microbial diversity in arid zones.
THE FUTURE
We look to consolidate new alliances with small companies
that conduct research and development, as this will be the
path to the developing and commercialization of new prod-
ucts.
Also, it is important to establish new spaces for prototypes
on a bigger scale than laboratory to satisfy the needs that
arise in applied investigation, and who will lead to future
commercialization.
And to keep up in our value proposal, the interaction of mi-
croorganism with minerals, on a natural and industrial en-
vironment, and the knowledge we can extract from that and
that could be applied on industrial processes, like remedia-
tion and medicine, as we already have microorganisms capa-
ble to be used in those industries.

“We are focused on renewing hope, hope for pathologies
or people that today have none. To improve quality of life.”

-Oscar Solar Jensen-
Name Cells for Cells S.A.
Adress San Carlos de Apoquindo 2200, Las Condes
Legal Representative Alejandro Guitiérrez Gasparini
Contact Oscar Solar Jensen
Phone +56 2-26181086
E-mail osolar@c4c.cl
Web Site www.c4c.cl
Founding Date 2010
Services Offered
Biotechnology Research and Development and Consultancy.

“Experts in cellular therapy”.

THE FUTURE
From our current development we are going to bring the first
cellular therapies to the market at the second half on 2014,
as they are currently in their finals stages of study and re-
search. We are currently working on a marketing plan to pro-
mote our therapies, focusing on giving medics the necessary
information to obtain positive results with their patients.
With this, we are also opening a new industry in Chile, as
cellular therapies are not regulated and there is no quali-
ty standards for its evaluation. That’s why we are furthering
the knowledge in this area, consolidating the market, gene-
rating trust in medical field, government and the patients in
general, to give a new alternative for diseases with few or
non-existant solutions.
WHO WE ARE
Cells for Cells, C4C, is the first chilean biotechnological com-
pany dedicated to research, development and commerciali-
zation of innovative cellular therapies founded on adult stem
cells. The therapies that today we offer are: Occular surface
reconstruction with limbal cells, and cardiac insuffiency.
WHAT WE DO
In biomedicine and healthcare industry we work on therapies
directed to diseases that are not resolved, looking to improve
quality of life. We also aspire to offer efficient and safe the-
rapies for chilean and American patients, through hospitals,
clinics and health centers that have the infrastructure nee-
ded to give them the best opportunity of recovery form dege-
nerative, autoimmune or malignant diseases, providing with
options in safe and proved cellular therapies.
Given the advance in this technology, it is of high technologi-
cal risk, reason why we are associated with prestigious cli-
nical research centers, mostly of universities, to work along-
side them. We also have investors that have supported us
through our foundation, giving us a sound financial basis for
the next five years.
Our installations are certified accordingly, and the therapies
thus produced are tightly regulated.

”The only way to capitalize the innovation developed by
national companies , especially those of the biotechnolog-
ical area, is through intellectual property”

-Arturo Covarrubias Vargas-
Name Covarrubias & Silva
Adress Enrique Foster Sur 39, piso 9
Legal Representative Arturo Covarrubias
Contact Arturo Covarrubias
Phone +56 2 - 28832700
E-mail acovarrubias@cs.cl
Web Site www.cs.cl
Founding Date October 15, 2010
Services Offered
Intellectual Property Legal Services

“Capitalizing biotechnological
innovation”.
Part of the professional team of patens and R&D protection that makes up Covarrubias & Silva: Ximena Caulier (Business Engi-
neer); José Manuel Delgado (Pharmaceutical Chemist); Daniela Castro (Biologist); Arturo Covarrubias (Lawyer), Augusto Perez
(Electronic and Mechanical Engineer) and Jessica Brizuela (Physics Engineer).

WHO WE ARE
Covarrubias & Silva is a specialized firm exclusively focused
to the Intellectual Property field, sprouted due to the rapid
economic growth that Chile has experienced during the last
10 years. A team of professionals working together for more
than a decade is ready to personally assist the client both in
Chile and abroad. We speak of a united and proactive group of
attorneys at law, biologists, chemists, engineers, designers
and paralegals, with thorough knowledge of the IP domestic
and foreign regulation of Industrial Property.
WHAT WE DO
Our firm has extensive and profound experience preparing
state of the art search reports; feasibility analysis; compar-
ative reports about scope of protection of patents; novelty
analysis, comparative reports about scope of protection of
utility models and design patents; drafting and filing of pat-
ents; utility model and design patents; filing and prosecution
in Chile or abroad for Convention patent applications (Paris
Convention) or PCT applications; analysis of examiner’s re-
port (Office Actions); strategies to overcome examiner’s ob-
jections, drafting and filing reply to examiner’s report; sur-
veillance and watch system; opposition analysis, briefs and
reply to oppositions, cancellation actions for Patents, Utility
Models and Design Patents (administrative regulation)
THE FUTURE
In the biotechnological world patents are essential. In Chile
some players in the biotechnology area say there is no need
for patents, since we are still a young nation. However, in
Germany, Japan, Switzerland, United States, and England,
nobody would believe that an entrepreneur would not protect
his or her innovation. With this in mind, we would like to plant
this need in the national biotechnology market so that peo-
ple and companies can protect their inventions by us giving
them the tools to quickly recognize when something could be
subjected to patents, what they should do in case of infrin-
gement, and (how to commercialize) the commercialization
of actives. That is the reason why we participate in judicial
cases of big Chilean industries in United States, Sweden, Ne-
therlands, Mozambique, Australia, China, among others.

“What move us is to implement new process lines for our
clients where before they only bought reagents and equip-
ment from us. The ability to listen, the ability to detect the
problems and to ask the right questions are the corner-
stones to deliver a solution”.

-Angela Diaz Ogaz-
Name Equilab SpA.
Adress El Quillay 627, Industrial Park Valle Grande, Lampa
Legal Representative Angela Diaz Ogaz
Contact Patricio Espinoza O.
Phone +56 2-29794725
E-mail pjespinoza@equilab.cl
Web Site www.equilab.cl
Founding Date 1981
Services Offered
· Equipment and reagents for laboratory use.
· Research and development in biomedicine.
· Engineering project execution under EPC modality.
· ADG R&D SpA.

“Reengineering, equipment
commercialization, bioimplants
biotechnology”.

WHO WE ARE
Equilab is a company with more than 30 years of experience
in the market, founded by Antonio Díaz Gema, focusing on
imports and distribution of reagents and equipment for la-
boratories. Five years ago this business model was reorien-
ted looking to involve the clients in a more close relationship
and to extend the reach of the company. Two new researches
gave the final push towards bioimplants development, and a
new unit for social responsibility was also added.
WHAT WE DO
Our new business looks to protect, patent, produce and com-
mercialize different products, and not just journal publica-
tions. The importance of intellectual property protection is
to be able to use it in the future for new advances and deve-
lopments associated with that particular research and tech-
nology.
One problem in particular has captivated our attention. Cer-
tain brain problems can only be treated by invasive surgeries
that include the partial removal of the cranial bone, and once
it is finished there are only two options: to put again the same
extracted bone (used roughly 10% of the time), or to use a re-
placement made from platinum or acrylic, an alternative that
is high in cost and have certain repercussions in the quality of
life of the patient. Because of this a current project involves
the recovery of the original bone and to maintain it in a way
that can be used again after the surgery, looking to obtain an
85% to 90% of bone recovery. For this we are working closely
with a Japanese university with which we have a technolo-
gical transfer agreement, allowing us to use a new freezing
technology for bone preserving.
THE FUTURE
The challenge for the next five years is to establish new ne-
tworks for financing and development of new projects, gea-
red towards clinic research and applications.
On the other hand we want to lead a change in the way bio-
technology is commercialized in Chile, showing a new path
made from experience, detecting the problems, making the
questions, and developing the solutions needed in our country.

“The concept behind Genoma Mayor is to go further than sequencing services, is to gen-
erate a high valued technology, projecting itself as a technology generating company.”
-Alejandro Poli L.-
Services Offered
Commercial platform with services of the Center for Genomics
and Bioinformatics of Universidad Mayor, for NGS sequentation,
bioinformatic, biotechnological solution’s development, genetic
analysis, personalized medicine, among others.
We are a company oriented to our clients and their needs,
allowing for a quick and efficient relationship between the in-
dustry and applied investigation, with all the capabilities of a re-
search center.
Services and on-demand research and development for com-
panies. Our clients are Recalcine, Pfizer, AMSA, many univer-
sities of Latin America and their research centers.
Name Genoma Mayor
Adress Américo Vespucio Sur 357
Postal Code/City Santiago
Legal Representative Verónica González B.
Contact Alejandro Poli L.
Phone +56 2-23281000 Anex.9207
E-mail apoli@genomamayor.com
Web Site www.genomamayor.com
Founding Date 2010

“Joining research and commercialization of
biotechnological processes and products”.

would like to stay on basic scientific investigation but would
want to see their products to reach market anyway.
The commercial platform of Genoma Mayor includes a team
of professionals that comes from different backgrounds, able
to develop projects to companies from a variety of industries,
like vaccine development, pharmaceutical products, preci-
sion genetic medicine among others.
THE FUTURE
The main goal of Genoma Mayor is to generate technology
of high value, projecting itself as a new technology developer
for genetic investigation, being recognized and validated by
the market as leaders in technology and research in geno-
mics and bioinformatics.
Integration is the first step, and for that we are thinking to
expand to other regions of Chile that will allow us to deve-
lop new relationships with innovation and research centers,
improving the quality of attention and services as well as its
value. A clear example is the accessibility patients have to
their tests, which could be available in different formats. In
the future this could allow a more personalized healthcare
services, especially in Chile, Peru and Colombia, the last
countries where Genoma Mayor already have alliances.
WHO WE ARE
Genoma Mayor is a company specialized in genetic analysis
that serves researchers and research centers in the areas
of genetics and informatics, and helping with the analysis of
genetic diseases to clinics and medical staff, using to this
end last generation equipment.
Their target market can be separated in two main groups: the
first is the area of research and development, which includes
researches usually associated with universities, or R&D de-
partments of the different industries who would require the
services provided. The second one is the healthcare area,
mainly preventive medicine, where genetic analysis can be
done to patients to evaluate their genetic predisposition to
certain diseases.
WHAT WE DO
Genoma Mayor is a platform that commercializes the pro-
ducts and services created by the Research and Develop-
ment Department of the Centro Genómico y Bioinformática
of Universidad Mayor. Among their services it can be found
personalized medicine, NGS sequencing, equipment and
applications, as an area for technological transfer as well.
Genoma Mayor supports those researchers that perform in-
vestigation and who most of the time don’t have the facilities
to further their research to an applied stage, or those who

“Neobiotec is part of Grupo IDIN, the first private center for research and development.
We have the knowledge to develop R&D oriented to the commercialization of new bio-
technological products and services”.
-Patricio Araneda H.-
Services Offered
· Biotechnological productos development:
Isolation, development and production of microorganisms as bi-
ostimulants alternatives, production of bioactive molecules and
others of commercial interest for production purposes, always
looking after the intellectual property and appropriability of the
results, resulting in future patents.
· Research and development services for companies:
Protocol and procedures design, execution and development of
test and technological solutions, concept tests, prototypes, fer-
mentation and bioproduction, with the objective of being a sup-
port on biotechnological and production projects.
Workshops
Practical and theoretical class. “Pathogen diagnosis with PCR”.
“Protein electrophoresis”. “Basic aspects of laboratory fermen-
tations”.
Corfo, private companies from different productive areas.
Name Neobiotec
Adress El Litre 1685, esquina Plath, Santa Inés
Postal Code/City 2530334 Viña del Mar
Legal Representative Patricio Araneda H.
Contact Patricio Araneda H.
Phone +56 32-2111306
E-mail p.araneda@neobiotec.cl
Web Site www.neobiotec.cl
Number of Colaborators 0-50
Founding Date 2012

“Research, development, innovation and
business in applied biotechnology”.

WHO WE ARE
Neobiotec, one of the companies of Grupo IDIN, dedicates
itself to research and development in biotechnology through
innovations that have applications on an industrial and com-
mercial level. We conduct our own investigations through in-
ternal projects, but we also service our clients that need to
perform research activities but don’t have the equipment and
staff to do it. These services include the production of mi-
croorganisms, biomolecules or active ingredients, develop-
ment of new products, and research in general, with the goal
of generating new products for commercialization.
WHAT WE DO
Neobiotec dedicates itself to activities of research and de-
velopment in biotechnology with a strong orientation to
scientific innovation, implementing and improving industrial
processes with applied biotechnology. Among its staff it has
high qualified professionals with ample experience in re-
search and development in biotechnology, and business as
well, making the capable of seeing the market potential of
new breakthroughs and ideas. It also has a project imple-
mentation and execution area to control the activities done
for internal purposes and the clients.
Currently we are working in the agricultural, environmental
and food sector, developing new biotechnological solutions for
their needs. It has also been capable of creating a spin-off in
the pharmaceutical industry, which has been very successful.
THE FUTURE
In five years’ time Neobiotec will be referring center for re-
search and development in biotechnology, counting with a
strong team of professionals and specialists of the mayor
areas in biotechnology, with better laboratories and equip-
ment, allowing us to generate new inventions, patents and
spin-offs.

“Today in the biotechnology area, while there is seriousness in the manipulation of living
organisms, there will be positive results for a environmental friendly society”.
-Jorge Quiroz Espinoza-
Services Offered
· Pipes and fat treatment.
· Livestock treatments.
· Municipal water plant’s treatment.
· Agricultural treatments.
· Renting of biological bathrooms.
· Maintenance and cleaning of Antofagasta’s maritime port.
· Duck control and maintenance.
· Green areas recovery.
Name Opessa Ltda.
Adress Baquedano 1047
Postal Code/City 12400000, Antofagasta
Legal Representative Jorge Quiroz Espinoza
Contact Jorge Quiroz Espinoza
Phone +56 55-2470061
E-mail opessa@opessa.cl
administracion@opessa.cl
Web Site www.opessa.cl
Founding Date 2008

“A company at the service
of biotechnology”.

WHO WE ARE
Opessa is a company dedicated to the commercialization,
distribution and maintenance of sanitary systems at the
Region of Antofagasta, north of Chile. We are commited to
develop and implement an appropriate integrated system of
SSMA, which is continuously improved to include new acti-
vities and developments. We work with different strains of
bacteria that are brought from different parts of the world,
mainly from Canada.
Some examples of this are:
· Fatty acids digesters, which are produced in wastewater
treatment plants.
· Organic sediments digesters.
· Oil digesters.
· Biostimulants and odour control.
WHAT WE DO
If there is an oil spill or contamination by other element in
a specific area, be it aquatic or terrestrial, a study must be
done to determine its impact. We deliver the products, in this
case bacteria, that consume the fatty acids and organic ma-
terial, and can be used afterwards as fertilizers. This treat-
ment can have a duration of months or years, reason why it
must be constantly monitored, implementing more effective
ways with new technological advances, combining the best of
them to achieve the desired results.
Our company holds the representation of a number of inter-
national companies that are interested in the chilean or Sou-
th America market, like Biomax, Bioenetics and E-Max In-
ternational, among others. Opessa works with the standards
ISO 9000 and 14000.
THE FUTURE
The biggest contribution that we could do to the future ge-
nerations is to leave them with and advanced biotechnology,
bringing new technologies and developing new and modern
laboratories to create new ones.
Opessa looks the future having a continuous growth, with cli-
net consolidation and a professional team that works towards
the same goal as the company.

Name Silva & Cia
Adress Hendaya 60, piso 4, Las Condes
Legal Representative Juan Pablo Silva
Contact Francisco Silva
Rodrigo León
Phone +56 2 24387000
E-mail mailsilva@silva.cl
Web Site www.silva.cl
Founding Date 1990
“A patent itself is useless if it’s not associated with a real business, more than just patent
registry, our main objective is to develop an biotechnological business for our customers,
adjusting it to the desired product marketing.”
-Rodrigo León-
Services Offered
The firm is specialized in Intellectual Property (IP), protects
commercial brands, invention patents, plant varieties, utility
models, industrial designs, industrial secrets, copyrights and
domain names. It provides advice in processing and conclusion
of Intellectual Property negotiations and provides a strong client
assistance in terms of intellectual property violations.
The firm participates in active form with different public and
private entities, e.g. Patenting with Pontificia Universidad
Católica de Chile (PUCV) in construction, vaccines and sur-
gical training support equipments and patenting with Uni-
versidad de los Andes in terms of forensic odontology and
molecular physiology.

“Protecting biotechnological
innovation”.

WHO WE ARE
In itself the patent has no value if it’s not associated with a
real business. Mora than just registering a patent, our spirit
is in the support we give to the concretion of a business, es-
pecially in the biotechnological industry, adjusting to the type
of commercialization that is wanted for the product.
Silva&Cía. is a buffet of lawyers oriented to the protection
of intellectual property of national and international compa-
nies. With more than 20 years of experience in areas such
branding, author’s rights defense, sanitary register, and
mainly, patenting.
Beyond its specialization, our team is composed of young
people with great experience whose services in representa-
tion are focalized towards the client, legal protection, elab-
oration of patenting strategies, patent defense, including an
innovation department that gives support to our clients in the
commercialization and valorization of their biotechnological
products and services.
WHAT WE DO
Our clients are laboratories, pharmaceutical companies,
universities with research and development programs,
alongside the most important investigation centers in Chile;
entities that are today developing different patents related to
stem cells, pharmaceutical products, formulations for active
ingredients. We are very involved with the national biotech-
nology industry, having among our team biotechnology engi-
neers and constant contact with international developments,
so as to give our clients an actual state of the art.
THE FUTURE
There is great potential in biotechnology and we are currently
involved with the Biotechnological Park of Chile project. We
are looking forward to work with more universities who are
showing being very active in new product and services de-
velopment while looking for new forms of innovation, and to
support the formation of new spin offs between the academic
and entrepreneurial world.
As our vision indicates, we look to contribute to the develop-
ment of our country, both on a material and spiritual level,
protecting one of the noblest faculties of de human being:
its creativity and innovation capacity, fundamental to the path
of progress, with a special emphasis, on be the creators of
networks to connect the different actors of Chilean biotech-
nology industry.

“We are beginning to create a new infrastructure for the EIB, where our main objective
is to expand the abilities of our students, but principally to open a space for the commu-
nity to reach a common goal in biotechnology”.
-Paola Poirrier-
Name Escuela de Ingeniería Bioquímica
Pontificia Universidad Católica de Valparaiso
Adress General Cruz 34
Postal Code/City 2362806, Valparaiso
Legal Representative Claudio Elórtegui Raffo
Contact Maritza Guerra
Phone +56 32-2273653
E-mail jdoceib@ucv.cl
Web Site www.eib.cl
Founding Date 1969
WHO WE ARE
The Biochemical Engineering School (EIB by its name in Spanish) is
an academic unit of the Pontificia Universidad Católica de Valparaí-
so (PUCV). It is not a company as its mission is to train and educate
professionals, master and doctoral grades.
What differentiate ourselves is that we have two types of undergra-
duate paths: the Biochemical Engineering and Bioprocess Engi-
neering. The first one will be capable of the design and operation
of bioreactor, and the planification and leadership of projects. The
second one will be in charge of operations and the line of production
with biological components. As both of them have a strong forma-
tion in the different industrial bioprocess and without specific men-
tions, they are a versatile professional that can adapt to almost any
situation maintaining a high rigurosity in their labor.

“We installed the concept of biotechnology in
Chile, and today we continue to deliver highly
trained professionals to work in the different are-
as that compose it”.

We also have to postgraduate programs, a master and doctoral stu-
dies that have a different approach to those in undergraduate stu-
dies. As they are specializations, the student will acquire tools rela-
ted to scientific research and its application to industrial processes,
even transforming the product of their investigation in commercial
products.
The EIB is the first school in Chile with bioprocesses in mind, crea-
ting the Bioprocess Engineering in 1968 and imparting it since 1969,
with 45 years at 2014. We are the only school training bioprocess
engineers, and all of our students have the possibility to access any
of our programs: the two undergraduate programs, master and
doctoral programs if the may wish so.
WHAT WE DO
We train professionals and graduates, making research and offe-
ring services of technical assistance. Our professionals are trained
to work in different industries, among them food (fermentations
and food processes that requires biotechnology), environment (de-
contamination, clean development mechanisms, carbon credits),
enzymatic transformations, and service industries as wastewater
processing.
Our relationship with the industry is with InnovaChile’s projects, and
the Technical Assistance Unit (UAT-EIB), which is part of the Núcleo
Biotecnología Curauma. With the UAT we offer services like tests
and experimental analysis to the industry.
In two months more we will be inaugurating our new building, cons-
tructed to expand laboratories, classrooms, and recreational areas,
effectively duplicating our current space. This will be operational on
august 2014, and we believe that this new building will allow for a
new integration of the different aspects and services offered by the
school, impacting in a positive way the students as they will be in a
closer contact with projects, the industrial and the academic world.
THE FUTURE
We have just finished the strategic plan for the development in
the next five years. We look ourselves as a visible and recognized
school, which motivate us to strengthen our efforts to become a
useful part of the community. We look towards a greater openness
with the community, not only with an academic and scientific point
of view, but as a social contribution which we believe is fundamen-
tal. We don’t want to be looked at just as researchers and teachers,
but as a recognized institution where the community can look inside
and be part of it. Biotechnology is to be everyday with everyone, that
helps the community in general to a better and improved quality of
life. That’s what we want to portray.

“We differentiate because we are a highly integrative center where we work transversely
in problem’s solutions, we generate work teams that mixes different points of view to
solve problems”.
-Patricio Manque-
Services Offered
DNA sequencing (Secuenciación de Novo, Resecuenciación,
Secuenciación de Amplicones, Transcriptómica (RNA-Seq), Se-
cuenciación de “Small ARN”).
Secuenciación Metagenómica (Metagenómica, Secuenciación
de amplicón de ARN ribosomal 16S y 18S, Metatranscriptómica).
Genetic Medicine (Genetic testing for cancer detection, testing
for hereditary disease detection, testing for reproductive health).
· Proyecto Anillo: CONICYT.
· Proyecto ViiV: ViiV Healthcare
· Proyecto Fondecyt Regular, CONICYT.
· CNRS International Research Network 2012
· International Cooperación Conicyt-USA 2012
· Conicyt-PIA 2012 Concurso de Anillos en Ciencia Antártica
· International Cooperación Conicyt-BMBF 2011
· Chilean Antarctic Institute, INACH 2010
· Fondecyt Chile-UMAS.
Name Centro de Genómica y Bioinformática
Adress Camino La Pirámide 5750, Huechuraba
Legal Representative Patricio Manque
Contact Viviana Valdés
Phone +56 2-23281424
E-mail patricio.manque@umayor.cl
viviana.valdes@umayor.cl
Web Site www.umayor.cl
Founding Date 1988

“Expanding biotechnologic
knowledge value”.

WHO WE ARE
Is the first research center in the country holding parallel
DNA massive sequencing, technology used to achieve full
genome sequences. The center was founded in 2009 under
Universidad Mayor’s Biotechnology Institute, The Center of
Genomics and Bioinformatics, is the first high complexity
center in Chile.
The center raises with a sight of becoming a genomic and
bioinformatics research referent in the country. We will help
as an universal platform, where all Chile’s researchers could
use our tool in their research projects. We have an “open
door” policy and we have participated in a high number of
Chilean projects from Arica to Magallanes.
WHAT WE DO
The center has an academic research topic:
Neuroscience research in neurodegeneration in diseases
like Alzheimer and Parkinson.
Microbiology and Immunity in vaccine development and di-
sease- pathogen interaction study.
Chilean native plant genomics for identification of interesting
genes and its biotechnological applications.
Environmental microbiology using genomics tools to charac-
terize Chilean ecosystem bacterial populations.
The center’s bioinformatic core is dedicated mainly in develo-
ping computational tools that allow to manipulate generated
data, also, sequencing services are offered across the coun-
try via “Genoma Mayor”, a business unit generated to grant
researchers the capacity to request access to all this techno-
logy unique in Chile for their research development.
This center is the only one of its kind because it grows in
research capability on all science topics that can use geno-
mics and bioinformatics tools, in the center researchers and
professionals who develop innovative, competitive and high
worldwide impact scientific advances.
THE FUTURE
Because we were the first center bringing genomic technolo-
gy in Chile, we want to be the first center bringing proteomics
to the country, which is protein structure and function study
on a bigger scale. In second place, we want to spread our re-
search platform aiming to knowledge generation for Chile’s
economic transformation. We want to mix the country and
future generations in sharing economy of knowledge.

“Our commitment is to integrate technology to the pharmaceutical industry, tested and
certified in its application, contributing to the first research steps until the technological
transfer to the industry, ready to start production.”
-Patricia González Jara-
Services Offered
Research and Development Veterinary
· Biological scaling services
· Immunocastration vaccines for swine (product)
· Immunocastration vaccines for canines (product development)
· Immunocastration vaccines for cattle (product development)
· Advisories development of research projects
Vaccimed (beneficiary) (Nov 2012 - Jul 2014) - Innova Project
12IDL4 L4-16273, New technology for pig immunocastration:
Optimizing pig production, 3rd Concurso/2012 - LINE 4: Pac-
kaging and Transfer
Vaccimed Associate (July 2012 - June 2015) Project PYT-FIA
2012-0055 Development and technology transfer of a polyva-
lent vaccine against mastitis. Recipient University of Chile.
Name Vaccimed S.A.
Adress Dr. Manuel Barros Borgoño 384,
Of. 24, Providencia
Legal Representative Patricia González Jara
Contact Carolina Cortés Brown
Phone +56 2-24458964
E-mail pgonzalez@vaccimed.cl
ccortes@vaccimed.cl
Web Site www.vaccimed.cl
Founding Date 2010

“Biotechnology and technological transfer
for the animal pharmaceutical industry”.

WHO WE ARE
Vaccimed is a start-up created from an academic back-
ground, oriented to research, development and transfer of
veterinary biotechnological solutions. It has a multidiscipline
team, with academics from Universidad de Chile, advisors
for technological management and marketing, able to con-
solidate technological transfer with products already testes
and most of them, licensed, which strengths the company’s
proposal to the market.
WHAT WE DO
Vaccimed developments are oriented to satisfy the needs
of the livestock industry and animal veterinary. Its currently
main asset is a technology that allows to control pigs by im-
mune-castration, but it could eventually be used in any type
of mammal by the way it was developed. Almost all animal
raised for livestock are castrated, an intervention that nega-
tively impacts on the production parameters. This new tech-
nology allows the industry to minimize the impact and thus
to have better yield.
Today this technology is applied only in pigs, and Vaccimed as
recently transferred it to Vencofarma, an important pharma-
ceutical laboratory.
We have the abilities and experience that allow us to continue
research in vaccines for the livestock industry.
We are currently developing a metabolite for cincuvirus pre-
vention, among two other projects that are on an initial stage.
The quality of our professionals, who are mainly from Uni-
versidad de Chile with a growing experience inresearch and
development, is what differentiate Vaccimed in the market.
We also have a department of marketing and for technologi-
cal commercialization.
THE FUTURE
The next steps of the company is to further the application of
the castration technology to bovines and other mammals in
use on an industrial scale. With this comes the need to grow
in infrastructure, implementing a new laboratory for vaccine
production.
As its mission indicates, future challenges include to become
the principal company in technological transfer of scientific
knowledge in biotechnology and veterinary biomedicine to
industry projects, becoming a biotechnological development
center for the livestock and animal industry, offering multiple
services to pharmaceutical and biotechnological companies,
animal health and life sciences.

Guide Chilean Biotechnology Companies

Guide Chilean Biotechnology Companies

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Ähnlich wie Guide Chilean Biotechnology Companies

Ähnlich wie Guide Chilean Biotechnology Companies (20)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Guide Chilean Biotechnology Companies